Related references
Note: Only part of the references are listed.Aggressive prolactinomas: how to manage?
Helene Lasolle et al.
PITUITARY (2020)
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey
Ulf Elbelt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Pituitary-Tumor Endocrinopathies
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Surgery for Prolactinomas to Date
Michael Buchfelder et al.
NEUROENDOCRINOLOGY (2019)
Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas
Adriana G. Ioachimescu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study
Winnie Liu et al.
PITUITARY (2018)
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
Helene Lasolle et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside
Anat Ben-Shlomo et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
Optimization of Single- and Dual-Color Immunofluorescence Protocols for Formalin-Fixed, Paraffin-Embedded Archival Tissues
Junko Kajimura et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)
Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway
Hongli Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
ErbB Receptor-Driven Prolactinomas Respond to Targeted Lapatinib Treatment in Female Transgenic Mice
Xiaohai Liu et al.
ENDOCRINOLOGY (2015)
Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors
Odelia Cooper et al.
ENDOCRINE (2014)
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
HER2/ErbB2 Receptor Signaling in Rat and Human Prolactinoma Cells: Strategy for Targeted Prolactinoma Therapy
Hidenori Fukuoka et al.
MOLECULAR ENDOCRINOLOGY (2011)
Heregulin Regulates Prolactinoma Gene Expression
George Vlotides et al.
CANCER RESEARCH (2009)
Estrogen Receptor-α Mediates the Epidermal Growth Factor-Stimulated Prolactin Expression and Release in Lactotrophs
Nira Ben-Jonathan et al.
ENDOCRINOLOGY (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients
Etienne Delgrange et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands
George Vlotides et al.
CANCER RESEARCH (2008)
Share Paper
